4
Changes in Ownership
COLLEGIUM PHARMACEUTICAL, INC Filed Acc 0001062993-23-022977
President and CEO sold 68,768 shares at an average $30.18 ($2,075,086)
- President and CEO acquired 68,768 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ciaffoni Joseph · President and CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-18 | Exercise or conversion : show line 1 in the form 10b5-1 | +27,798 | $21.34 | $593,209 | 302,798 | D |
| 2023-12-18 | Sale : show line 2 in the form 10b5-1 | −27,798 | $30.04 | $834,935 | 275,000 | D |
| 2023-12-19 | Exercise or conversion : show line 3 in the form 10b5-1 | +14,516 | $21.34 | $309,771 | 289,516 | D |
| 2023-12-19 | Sale : show line 4 in the form 10b5-1 | −14,516 | $30.03 | $435,942 | 275,000 | D |
| 2023-12-20 | Exercise or conversion : show line 5 in the form 10b5-1 | +26,454 | $21.34 | $564,528 | 301,454 | D |
| 2023-12-20 | Sale : show line 6 in the form 10b5-1 | −26,454 | $30.40 | $804,210 | 275,000 | D |
| Open-market sales · 68,768 sh · avg $30.18 · $2,075,086 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-12-18 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Purchase) | −27,798 | 62,202 | D |
| 2023-12-19 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Purchase) | −14,516 | 47,686 | D |
| 2023-12-20 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (Right to Purchase) | −26,454 | 21,232 | D |
Loading xslF345X05/form4.xml…